Season 4 · Episode 6
S4 | E6 | AI in Drug Discovery with Josh Haimson - Inductive Bio
ThinkData Podcast · Dataworks Group Limited
February 8, 202626m 19s
Audio is streamed directly from the publisher (episodes.captivate.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
AI is everywhere in biotech, but where does it genuinely create impact?
In this episode of the ThinkData Podcast, I sat down with Josh Haimson, Co-Founder and CEO of Inductive Bio, to explore how AI-driven virtual chemistry labs are transforming drug discovery.
We cover:
- Where AI truly outperforms traditional approaches in drug development
- Why computational models are finally earning real trust from scientists
- What Inductive Bio’s Series A unlocked, and how they’re balancing speed vs depth
- The role of industry partnerships and early adopters in shaping the platform
- Where are the biggest AI opportunities in drug discovery over the next 3–5 years
A grounded, technical, and refreshingly honest conversation about the future of AI-powered therapeutics.